Health Technology Assessment (HTA) Decision Summary Update - Xiaflex® (Collagenase Clostridium Histolyticum)
SAPACT Assessment outcome on Xiaflex® (Collagenase Clostridium Histolyticum) for treatment of Dupuytren’s contracture
SAPACT Assessment outcome on Xiaflex® (Collagenase Clostridium Histolyticum) for treatment of Dupuytren’s contracture